Prosecution Insights
Prosecution Insights
5 pending office actions • 3 clients • 4 examiners • 3 art units • 0 of 5 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (40%) |
| §103 only | 1 (20%) |
| Double-patenting only | 1 (20%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, HIEP VAN | 2 | 55.2% | +29.3% |
| LAM, ELIZA ANNE | 1 | 38.1% | +31.2% |
| FRONDA, CHRISTIAN L | 1 | 82.6% | +14.0% |
| DRISCOLL, LORA E BARNHART | 1 | 31.6% | +20.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18910526 | STABILIZED FORMULA OF CROTOXIN | FRONDA, CHRISTIAN L | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18654702 | SMART DOSING FOR CANCER THERAPY | NGUYEN, HIEP VAN | 44d overdue |
| 18774363 | NANOEMULSION COMPOSITIONS OF TAXOID DRUGS, AND METHODS FOR THE USE THEREOF TO TARGET CANCER CELLS AND CANCER STEM CELLS | DRISCOLL, LORA E BARNHART | 27d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18654702 | SMART DOSING FOR CANCER THERAPY | NGUYEN, HIEP VAN | 44d overdue |
| 18939802 | SMART NUTRITION DOSING | LAM, ELIZA ANNE | 3d overdue |
| 18774363 | NANOEMULSION COMPOSITIONS OF TAXOID DRUGS, AND METHODS FOR THE USE THEREOF TO TARGET CANCER CELLS AND CANCER STEM CELLS | DRISCOLL, LORA E BARNHART | 27d |
| 19170365 | SMART DOSING FOR CANCER THERAPY | NGUYEN, HIEP VAN | — |
| 18910526 | STABILIZED FORMULA OF CROTOXIN | FRONDA, CHRISTIAN L | — |
| Client (Assignee) | Pending OAs |
|---|---|
| OptimDosing LLC | 3 |
| Celtic Biotech Ltd. | 1 |
| Northeastern University | 1 |
| Art Unit | Apps |
|---|---|
| 3686 | 2 |
| 3681 | 1 |
| 3991 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19170365 | SMART DOSING FOR CANCER THERAPY | Optimdosing LLC | NGUYEN, HIEP VAN | 3686 | — | Non-Final OA | — | Pending | Apr 04, 2025 |
| 18939802 | SMART NUTRITION DOSING | Optimdosing LLC | LAM, ELIZA ANNE | 3681 | §103 | Final Rejection | 3d overdue | Pending | Nov 07, 2024 |
| 18910526 | STABILIZED FORMULA OF CROTOXIN | Celtic Biotech Ltd. | FRONDA, CHRISTIAN L | DP | Non-Final OA | — | Pending | Oct 09, 2024 | |
| 18774363 | NANOEMULSION COMPOSITIONS OF TAXOID DRUGS, AND METHODS FOR THE USE THEREOF TO TARGET CANCER CELLS AND CANCER STEM CELLS | Northeastern University | DRISCOLL, LORA E BARNHART | 3991 | §101 | Final Rejection | 27d | Pending | Jul 16, 2024 |
| 18654702 | SMART DOSING FOR CANCER THERAPY | Optimdosing LLC | NGUYEN, HIEP VAN | 3686 | §101 | Non-Final OA | 44d overdue | Pending | May 03, 2024 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial